BNP Paribas Financial Markets
VERA icon

BNP Paribas Financial Markets’s Vera Therapeutics VERA Stock Holding History

BNP Paribas Financial Markets’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12M Sell
298,149
-176,519
-37% -$7.61M 0.01% 1468
2025
Q4 		$24M Buy
474,668
+220,692
+87% +$7.84M 0.01% 1073
2025
Q3 		$7.38M Buy
253,976
+143,424
+130% +$3.32M ﹤0.01% 1735
2025
Q2 		$2.6M Buy
110,552
+92,108
+499% +$2.07M ﹤0.01% 2296
2025
Q1 		$443K Sell
18,444
-5,930
-24% -$191K ﹤0.01% 3261
2024
Q4 		$1.03M Buy
+24,374
New +$1.08M ﹤0.01% 2808
2022
Q4 		– Sell
-5,183
Closed -$110K – 4637
2022
Q3 		$110K Buy
+5,183
New +$97K ﹤0.01% 3726

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BNP Paribas Financial Markets's VERA Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Vera Therapeutics (VERA) stake by 37% in Q1 2026, selling an estimated $7.61M and leaving 298,149 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #1468.

BNP Paribas Financial Markets first reported a position in VERA in Q3 2022 and has held it in 7 quarters since. The position peaked at $24M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • BNP Paribas Financial Markets held 298,149 shares of Vera Therapeutics worth $12M as of Q1 2026.
  • BNP Paribas Financial Markets sold 176,519 Vera Therapeutics shares in Q1 2026, an estimated $7.61M.
  • Vera Therapeutics made up 0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #1468 holding.
  • BNP Paribas Financial Markets first reported a position in Vera Therapeutics in Q3 2022 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Vera Therapeutics position peaked at $24M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.